Holen Sie sich die Stockscreener-App
31.85
3.27%
1.01
Handel nachbörslich:
30.33
-1.52
-4.77%
Schlusskurs vom Vortag:
$30.84
Offen:
$31.46
24-Stunden-Volumen:
439.56K
Relative Volume:
1.20
Marktkapitalisierung:
$1.29B
Einnahmen:
$1.46B
Nettoeinkommen (Verlust:
$92.09M
KGV:
14.12
EPS:
2.2555
Netto-Cashflow:
$47.29M
1W Leistung:
+1.89%
1M Leistung:
-6.82%
6M Leistung:
-21.18%
1J Leistung:
+32.93%
1-Tages-Spanne:
$31.02
$32.00
1-Wochen-Bereich:
$30.67
$33.00
52-Wochen-Spanne:
$23.57
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
31.85 | 1.29B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Phibro Animal Health Corp (PAHC) Institutional Confidence - TradingKey
Phibro Animal Health Corp (PAHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Phibro Animal Health Corp (PAHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Phibro Animal Health Corp (PAHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Phibro Animal Health Corp (PAHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Phibro Animal Health Corp (PAHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What Makes Phibro (PAHC) a New Buy Stock - Yahoo Finance
Phibro Animal Health Corp (PAHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
[144] PHIBRO ANIMAL HEALTH CORP SEC Filing - Stock Titan
Should You Continue to Hold PAHC Stock in Your Portfolio? - Yahoo Finance
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares? - Yahoo Finance
PAHC News | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
PAHC - Finviz
PAHC Stock: What's Driving Phibro's Animal Health Growth - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price Today & Analysis - Gotrade
Phibro Animal Health (PAHC) Q3 2026 Earnings Call Transcript - MLQ.ai
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value - Yahoo Finance
A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Volatility - simplywall.st
Why Phibro Animal Health (PAHC) Stock Is Trading Up Today - Yahoo Finance
Phibro Animal Health Up 10% After Insider Move - Bez Kabli
Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock - Investing.com India
Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) director buys 10,000 shares in market - Stock Titan
Phibro (PAHC) Q3 2026 Earnings Transcript - AOL.com
Phibro Animal Health Lifts Outlook Amid Strong Q3 - TipRanks
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Implied Volatility Surging for Phibro Stock Options - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Fall 3.1% -- GF Value Sa - GuruFocus
After Plunging 38.0% in 4 Weeks, Here's Why the Trend Might Reverse for Phibro (PAHC) - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro's CEO transition puts this insider sale in context - AOL.com
Phibro's CEO transition puts this insider sale in context - The Motley Fool
Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan - Stock Titan
Phibro leaders to address investors at Stifel 'Jaws & Paws' in New York - Stock Titan
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference - Yahoo Finance
PAHC Technical Analysis & Stock Price Forecast - Intellectia AI
Phibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector Pressure - Insider Monkey
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Phibro (PAHC) Q1 2026 Earnings: EPS $0.76 Beats EstimatesSocial Buy Zones - Newser
PAHC Stock Price, Quote & Chart | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC) - Stock Titan
PAHC Maintained by Citigroup -- Price Target Lowered to $44 - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health Sales Grow 10 Percent to 383 Million Dollars - HarianBasis.co
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):